Table 5.

Summary of Worst Adverse Event Definitely, Probably, or Possibly Related to Treatment per Patient occurring Post Surgery and Prior to Chemotherapy or within 60 days of Surgery for Patients who did not have Post-operative Chemotherapy

Adverse Event	Grade	Capecitabine/Ir inotecan/RT (n=47)		Capecitabine/O xaliplatin/RT (n=51)
Worst non-hematologic	1	6	(13%)	9	(18%)
	2	14	(30%)	12	(24%)
	3	8	(17%)	8	(16%)
	4	1	(2%)	1	(2%)
	5	0	(0%)	0	(0%)
Worst overall	1	4	(9%)	9	(18%)
	2	16	(34%)	14	(27%)
	3	8	(17%)	9	(18%)
	4	1	(2%)	1	(2%)
	5	0	(0%)	0	(0%)

Adverse events were graded with CTCAE version 3.0